Archives of Toxicology with contributions from Matthew Bentley
Oxford, UK – June, 2018
View a recently released article in the Archives of Toxicology, with contributions from Matt Bentley, Eurofins Bioanalytical Services, Oxford UK site supporting clinical development for GDNF for the treatment of patients with Parkinson’s Disease.
Springer Nature published "Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: absence of local or cerebellar toxicity" in Archives of Toxicology.
For more information, please contact us.
About Eurofins Pharma Bioanalytical Services- a global leader in large molecule bioanalysis
Eurofins Bioanalytical Services is a powerhouse large molecule-focused bioanalytical and biomarker contract research organization that, since its formation in 2003, has actively supported the evolving needs of companies developing biotherapeutics and biosimilars.
At our state-of-the-art testing facilities in Oxford, UK and St. Charles, USA we develop, transfer and validate large molecule PK, ADA and biomarker assays to our client’s specifications as well as offer a comprehensive listing of pre-qualified assays spanning decades of experience. With industry-leading capacity, we support studies ranging from a single plate to large multinational Phase III clinical trials. We have the capacity to handle variable sample numbers and large volumes to meet the needs of our clients.